Matches in Wikidata for { <http://www.wikidata.org/entity/Q61833652> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q61833652 description "article scientifique publié en 2014" @default.
- Q61833652 description "artículu científicu" @default.
- Q61833652 description "im September 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61833652 description "wetenschappelijk artikel" @default.
- Q61833652 description "наукова стаття, опублікована у вересні 2014" @default.
- Q61833652 name "984TiPPHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS (PTS) WITH CD30+ MATURE T-CELL LYMPHOMAS (MTCL)" @default.
- Q61833652 name "984TiPPHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS" @default.
- Q61833652 type Item @default.
- Q61833652 label "984TiPPHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS (PTS) WITH CD30+ MATURE T-CELL LYMPHOMAS (MTCL)" @default.
- Q61833652 label "984TiPPHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS" @default.
- Q61833652 prefLabel "984TiPPHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS (PTS) WITH CD30+ MATURE T-CELL LYMPHOMAS (MTCL)" @default.
- Q61833652 prefLabel "984TiPPHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS" @default.
- Q61833652 P1433 Q61833652-1A92D25B-75F6-4095-AD03-8D00E03B2406 @default.
- Q61833652 P1476 Q61833652-F8153CC1-B7D6-45FE-A8CA-D5EFC71740E6 @default.
- Q61833652 P2093 Q61833652-19B2CF3D-4B61-4719-93F0-631A9E09D3EB @default.
- Q61833652 P2093 Q61833652-49B6D5ED-1B53-46C6-8AFA-8CA578E61F15 @default.
- Q61833652 P2093 Q61833652-7FEDB959-2552-4606-9CD6-22BDEF24D465 @default.
- Q61833652 P2093 Q61833652-91F361E0-8252-4B6A-A1D4-543838AD5860 @default.
- Q61833652 P2093 Q61833652-ABE8A2EE-74F1-478C-BD57-BAAF2BABB159 @default.
- Q61833652 P2093 Q61833652-C68A99CC-12A0-45CB-8627-E06F4BAA9DF4 @default.
- Q61833652 P2093 Q61833652-E76B5C51-18A0-4EF1-92A4-7AA86B6F5780 @default.
- Q61833652 P304 Q61833652-2E0E4464-8910-40B6-8B18-BFF5FE59FBED @default.
- Q61833652 P31 Q61833652-EDB8E12B-58E4-468E-B98C-819F91D9160C @default.
- Q61833652 P356 Q61833652-E6D84DDA-5B29-49E6-AF77-A424B2FEAA6A @default.
- Q61833652 P433 Q61833652-2E5A0B65-C67F-4962-8811-0C38B82CFD07 @default.
- Q61833652 P478 Q61833652-286BD624-A158-4074-97E6-E2335DFEA15F @default.
- Q61833652 P577 Q61833652-83B41018-B5C3-449B-A54A-3FC1D60DFCA8 @default.
- Q61833652 P356 MDU339.41 @default.
- Q61833652 P1433 Q326122 @default.
- Q61833652 P1476 "984TiPPHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS (PTS) WITH CD30+ MATURE T-CELL LYMPHOMAS (MTCL)" @default.
- Q61833652 P2093 "B. Pro" @default.
- Q61833652 P2093 "D. Huebner" @default.
- Q61833652 P2093 "D.A. Kennedy" @default.
- Q61833652 P2093 "E.K. Larsen" @default.
- Q61833652 P2093 "L.H. Trümper" @default.
- Q61833652 P2093 "O. O'Connor" @default.
- Q61833652 P2093 "T. Illidge" @default.
- Q61833652 P304 "iv338-iv338" @default.
- Q61833652 P31 Q13442814 @default.
- Q61833652 P356 "10.1093/ANNONC/MDU339.41" @default.
- Q61833652 P433 "suppl_4" @default.
- Q61833652 P478 "25" @default.
- Q61833652 P577 "2014-09-01T00:00:00Z" @default.